Nestec S.a.

Institut De La Research Agronomique

Societe Des Produits Nestle S.a.

Myriam Richelle

Karlheinz Bortlik

Pierre Lambelet

Denis Breuille

Claudia Roessle

Markus Baur

Gary Williamson

Marco Enrico Turini

Francoise Saucy

Eliane Duruz

Gayle Crozier-Willi

Guy Dutot

Paul André Finot

Andrea M Pfeifer

Isabelle Bureau-Franz

Angus Moodycliffe

Andrea M A Pfeifer

Ivana Jankovic

Christiane Obled

Maarit Rein

Heike Steiling

Inge Lise Nielsen

Elizabeth Offord-Cavin

The present invention pertains to a composition for preventing, decreasing and/or treating skin and hair/coat disorders, such as is effected by inflammatory reactions, environmental factors, ageing or cancer. In particular, the present invention relates to the use of flavanones compounds or their derivatives in nutritional, cosmetic or pharmaceutical compositions for improvement of human or pet animal skin and coat conditions.

Composition for improving skin, hair and coat health containing flavanones

Compositions that provide health benefits and methods regarding same are presented. In an embodiment, the present invention provides a primary composition comprising at least one carotenoid-containing material, enriched in Z isomers of the carotenoid compound. For example, the carotenoid-containing material contains by weight a greater percentage of an isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof than of 13-Z isomer.

Stable and bioavailable compositions of isomers of carotenoids for skin and hair

The present invention relates to methods for a long-term and sustained release of flavonoids, in particular rhamnose-containing flavonoids, and for prolonging the uptake of said flavonoids in the gastro-intestinal tract. It further relates to compositions comprising said flavonoid and &#x3b1;-rhamnosidase. It also encompasses compositions comprising hesperidin and hesperetin-7-glucoside.

Long-lasting absorption of flavonoids

The invention relates to a primary composition in which at least one lipophilic bioactive compound is mixed with a whey protein, present in an amount effective to increase the bioavailability of the lipophilic bioactive compound. The invention also relates to an oral composition that contains the primary composition in a foodstuff, in a food supplement, or in a pharmaceutical preparation, and to a cosmetic preparation that contains the primary composition. Methods for increasing the bioavailability of the lipophilic bioactive compound and providing increased photostability and oxidation resistance are also provided.

Primary composition comprising a lipophilic bioactive compound

A composition for use as a medicament, functional food or nutritional product is described which comprises at least one lipid wherein the lipid provides greater than 35% total energy of the composition. A preferred embodiment comprises a n-6/n-3 fatty acid ratio of about 2/1 to 7/1. In addition, a method of preparing the composition; use of the composition in the manufacture of a medicament, functional food or nutritional product; and a method of treatment or treatment or prevention of sepsis or inflammatory shock which comprises administering an effective amount of the composition are described.

High lipid diet

A primary composition that includes at least one lipophilic bioactive compound and a whey protein in an amount effective to increase the bioavailability of the lipophilic bioactive compound, and methods of forming the same. Also, an oral composition that contains the primary composition in a foodstuff, in a food supplement, in a cosmetic preparation or in a pharmaceutical preparation, and methods of forming the same.

Method for increasing bioavailability of lipophilic bioactive compounds

A composition for use as a medicament or nutritional product is described which comprises at least one lipid wherein the lipid provides greater tan 35% total energy of the composition. A prefered embodiment comprises a n-6/n-3 fatty acid ratio of about 2/1 to 7/1. In addition, a method of preparing the composition; use of the composition in the manufacture of a medicament or nutritional product; and a method of treatment or prevention of sepsis or inflammatory shock which comprises administering an effective amount of the composition are described.

Growing community of inventors

Savigny, Switzerland

Myriam Richelle